logo
Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod

Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod

Globe and Mail22-05-2025
FDA approvals are often market-moving events, and today a micro-cap biotech company saw its shares surge after receiving Rare Pediatric Disease designation from the FDA.
Relief Therapeutics Holding SA (OTCQB:RLFTF) (OTCQB:RLFTY) announced this morning that the U.S. FDA has granted Rare Pediatric Disease (RPD) designation to its drug candidate RLF-TD011 for the treatment of epidermolysis bullosa (EB), a rare genetic skin disorder. This follows a previous Orphan Drug Designation for the same condition. RLF-TD011 is a hypotonic acid-oxidizing solution containing hypochlorous acid, developed to offer antimicrobial and anti-inflammatory effects while promoting a healing wound environment. The company has reported encouraging clinical results, highlighting the drug's potential to improve EB wound care by modulating the wound microbiome and reducing harmful bacterial colonization.
"The FDA's decision to grant Rare Pediatric Disease designation to RLF-TD011 underscores both the critical need for new options for patients living with EB and the potential of our investigational therapy," said Giorgio Reiner, chief scientific officer of Relief. "We look forward to continued engagement with the FDA and to sharing the next steps in our development plan following our upcoming pre-IND meeting."
The FDA grants RPD designation to product candidates targeting serious or life-threatening diseases that primarily affect individuals aged 18 years or younger and impact fewer than 200,000 people in the U.S. Companies that receive marketing approval for an RPD-designated indication may be eligible-subject to certain conditions, including congressional reauthorization of the program for designations granted after December 20, 2024-to receive a Priority Review Voucher (PRV), which grants expedited FDA review for a future marketing application. These vouchers are transferable; in May 2025, a PRV awarded following the approval of a treatment for a rare form of EB was sold for $155 million.
Shares of RLFTF are surging on the news, currently up 49.62% at $3.89 while shares of RLFTY trade up 40.34% at $4.07 in late-morning trading.
Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
View more of this article on AllPennyStocks.com.
About AllPennyStocks.com Media, Inc.:
Founded in 1999, AllPennyStocks.com is one of North America's leading platforms for micro-cap insights.
Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders.
AllPennyStocks.com is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals.
Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today.
Contact:
AllPennyStocks.com Media, Inc.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stock Market Today: Tech Weakness Pulls S&P 500, Nasdaq Lower as Dow Holds Steady
Stock Market Today: Tech Weakness Pulls S&P 500, Nasdaq Lower as Dow Holds Steady

Globe and Mail

time28 minutes ago

  • Globe and Mail

Stock Market Today: Tech Weakness Pulls S&P 500, Nasdaq Lower as Dow Holds Steady

U.S. stocks finished mixed on Tuesday as a sell-off in tech stocks weighed on the broader market. The S&P 500 (SNPINDEX: ^GSPC) fell 37.78 points, or 0.6%, to 6,411.37, while the Nasdaq Composite (NASDAQINDEX: ^IXIC) tumbled 314.82 points, or 1.5%, to 21,314.95. Semiconductor shares led the decline as Nvidia (NASDAQ: NVDA) lost 3.5%, Advanced Micro Devices (NASDAQ: AMD) dropped 5.4%, and Broadcom (NASDAQ: AVGO) slipped 3.6%. Software maker Palantir (NASDAQ: PLTR) plunged more than 9%, making it the S&P 500's weakest performer. The Dow Jones Industrial Average (DJINDICES: ^DJI) bucked the trend, edging up 10.45 points, or 0.02%, to 44,922.27. Gains in financials and industrials offset pressure from technology, allowing the blue-chip benchmark to close slightly higher. The day's divergence across indices underscored investors' rotation toward value and dividend-paying stocks, even as markets brace for upcoming economic data and fresh commentary from the Federal Reserve later this week. Market data sourced from Google Finance and Yahoo! Finance on Tuesday, Aug. 19, 2025. Should you invest $1,000 in S&P 500 Index right now? Before you buy stock in S&P 500 Index, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and S&P 500 Index wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Daily Stock News has no position in any of the stocks mentioned. This article was generated with GPT-4o, OpenAI's large-scale language generation model and has been reviewed by The Motley Fool's AI quality control systems. The Motley Fool has positions in and recommends Advanced Micro Devices, Nvidia, and Palantir Technologies. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.

Alberta government to cover COVID-19 shots for health-care workers in policy reversal
Alberta government to cover COVID-19 shots for health-care workers in policy reversal

CTV News

time28 minutes ago

  • CTV News

Alberta government to cover COVID-19 shots for health-care workers in policy reversal

In a partial policy reversal, Alberta's government said Tuesday it will cover the cost of COVID-19 vaccinations for health-care workers. Maddison McKee, spokesperson to Primary and Preventative Health Services Minister Adriana LaGrange, said in an email that COVID-19 vaccine coverage will be extended to all health-care workers this fall under the first phase of the province's vaccination rollout. 'Immunization will remain voluntary,' said McKee. It comes two months after the government said most Albertans, including health workers, would have to pay for COVID-19 shots this season. Public health experts and health-care unions called it irresponsible to force front-line workers to pay for protection in the workplace. Premier Danielle Smith has said the aim of the new policy is to prevent wastage, after some $135 million was spent on unused doses. She's also pointed out that other vaccinations come with an out-of-pocket fee. The government did not immediately respond to questions about what prompted the shift. The Health Sciences Association of Alberta is one of several unions representing health-care workers that have been publicly pressing the government for months. President Mike Parker said his members demanded the change at the bargaining table, but the government decided to make it a blanket policy instead. The union reached a new tentative agreement last week with employers on wages and benefits, but it is yet to be ratified. 'This is both in the interest of our members and the public to make sure that these folks stay healthy and on the job,' Parker said. 'I'm pleased to see that it's now going to be inclusive of all health-care workers from the work that we did.' Parker said the government's next step should be allowing everyone to get vaccinated, if they want, free of charge. The government hasn't finalized how much other Albertans will need to pay, but an estimated cost to buy each shot is $110. The province said in June those who have compromised immune systems, people on social programs and seniors in congregate settings will be covered. Alberta Opposition NDP Leader Naheed Nenshi called on the United Conservative Party government to give the shot to all seniors at no cost. 'They continue to make this up as they go along. Albertans deserve better than this incompetence and confusion,' he said in a statement Tuesday. Last week, the government opened online pre-ordering for the COVID-19 vaccine alongside flu shots. Albertans still need to book appointments for the shots, starting in October. Those who don't pre-order by a Sept. 30 deadline can still book an appointment once doses become available. However, the specifics of the qualifying health conditions for a free shot have not been released. LaGrange's office has said details of the plan are still being finalized -- including the updated vaccination schedule, eligible conditions, exact locations and administrative fee for COVID-19 vaccines. The province said it has ordered 485,000 doses of COVID-19 vaccine for the fall -- about 250,000 fewer doses than were administered last year. The federal government put provinces in charge of buying COVID-19 shots this year, but Alberta's COVID-19 policy makes it an outlier. The province has said local pharmacies will no longer get a supply of COVID-19 shots, which will only be available through public health clinics through a phased delivery. The government has said the new approach would help it better know what to order in coming years. Public health-care experts have also said the province's COVID-19 strategy will create more barriers to getting vaccinated and lead to higher health-care system costs, as more people develop severe complications. Critics have also warned that excluding pharmacies from the rollout will limit access for rural residents, shift workers and others who rely on community-based care. Canada's National Advisory Committee on Immunization recommends that all adults 65 or older and health-care workers get the shot. Routine influenza vaccines continue to be publicly covered. This report by The Canadian Press was first published Aug. 19, 2025. Lisa Johnson, The Canadian Press

Alberta to cover COVID vaccines for health-care workers after all
Alberta to cover COVID vaccines for health-care workers after all

CBC

time28 minutes ago

  • CBC

Alberta to cover COVID vaccines for health-care workers after all

Social Sharing In a partial policy reversal, Alberta's government said Tuesday it will cover the cost of COVID-19 vaccinations for health-care workers. Maddison McKee, spokesperson to Primary and Preventative Health Services Minister Adriana LaGrange, said in an email that COVID-19 vaccine coverage will be extended to all health-care workers this fall under the first phase of the province's vaccination rollout. "Immunization will remain voluntary," said McKee. It comes two months after the government said most Albertans, including health workers, would have to pay for COVID-19 shots this season. Public health experts and health-care unions called it irresponsible to force front-line workers to pay for protection in the workplace. Premier Danielle Smith has said the aim of the new policy is to prevent wastage, after some $135 million was spent on unused doses. The government hasn't finalized how much other Albertans will need to pay, but an estimated cost to buy each shot is $110. The province said in June those who have compromised immune systems, people on social programs and seniors in congregate settings will be covered. Albertans can now book their COVID-19 vaccines for the fall, but it comes with a cost 8 days ago The way Albertans can receive the COVID-19 vaccine has now changed. For some, it will soon come with a cost. The provincial government launched a new vaccination policy to reduce waste. But critics say making Albertans pay for vaccinations puts everyone at risk. Last week, the government opened online pre-ordering for the COVID-19 vaccine alongside flu shots. Albertans still need to book appointments for the shots, starting in October. Those who don't pre-order by a Sept. 30 deadline can still book an appointment once doses become available. However, the specifics of the qualifying health conditions for a free shot have not been released. LaGrange's office has said details of the plan are still being finalized — including the updated vaccination schedule, eligible conditions, exact locations and administrative fee for COVID-19 vaccines. Alberta Opposition NDP Leader Naheed Nenshi called on the United Conservative Party government to give the shot to all seniors at no cost. "They continue to make this up as they go along. Albertans deserve better than this incompetence and confusion," he said in a statement Tuesday. The province said it has ordered 485,000 doses of COVID-19 vaccine for the fall — about 250,000 fewer doses than were administered last year. The federal government put provinces in charge of buying COVID-19 shots this year, but Alberta's COVID-19 policy makes it an outlier. The province has said local pharmacies will no longer get a supply of COVID-19 shots, which will only be available through public health clinics through a phased delivery. The government has said the new approach would help it better know what to order in coming years. Public health-care experts have also said the province's COVID-19 strategy will create more barriers to getting vaccinated and also lead to higher health-care system costs, as more people develop severe complications. Critics have also said excluding pharmacies from the rollout will limit access for rural residents, shift workers and others who rely on community-based care. Canada's National Advisory Committee on Immunization recommends that all adults 65 or older and health-care workers get the shot.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store